Gotowa bibliografia na temat „Cancer ratio”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Zobacz listy aktualnych artykułów, książek, rozpraw, streszczeń i innych źródeł naukowych na temat „Cancer ratio”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Artykuły w czasopismach na temat "Cancer ratio"
Atchyuta, M., I. V. Renuka, P. Premalatha, PAV Krishnamacharyulu, Chitturi Ramya, and U. Pravallika. "Lymphnodal Ratio in Prognostication of Stage III Colon Cancer." Indian Journal of Pathology: Research and Practice 8, no. 2 (2019): 153–58. http://dx.doi.org/10.21088/ijprp.2278.148x.8219.4.
Pełny tekst źródłaVerma, Akash, Rucha S. Dagaonkar, Dominic Marshall, John Abisheganaden, and R. W. Light. "Differentiating Malignant from Tubercular Pleural Effusion by Cancer Ratio Plus (Cancer Ratio: Pleural Lymphocyte Count)." Canadian Respiratory Journal 2016 (2016): 1–6. http://dx.doi.org/10.1155/2016/7348239.
Pełny tekst źródłaEruku, Dr Baburao. "Differentiating malignant effusions from other exudative effusions by cancer ratio and cancer ratio plus." International Journal of Advanced Research in Medicine 3, no. 2 (2021): 525–29. http://dx.doi.org/10.22271/27069567.2021.v3.i2h.453.
Pełny tekst źródłaEllis, Libby, Aurélien Belot, Bernard Rachet, and Michel P. Coleman. "The Mortality-to-Incidence Ratio Is Not a Valid Proxy for Cancer Survival." Journal of Global Oncology, no. 5 (December 2019): 1–9. http://dx.doi.org/10.1200/jgo.19.00038.
Pełny tekst źródłaAbhinav, Manish, Garg Nita, and Sharma Narotam. "Serum CA125, CEA, CA125/CEA ratio and LDH levels in Ovarian Cancer." Indian Journal of Genetics and Molecular Research 7, no. 1 (2018): 17–20. http://dx.doi.org/10.21088/ijgmr.2319.4782.7118.3.
Pełny tekst źródłaFujisawa, Daisuke, Shino Umezawa, Maiko Fujimori, and Mitsunori Miyashita. "Prevalence and associated factors of perceived cancer-related stigma in Japanese cancer survivors." Japanese Journal of Clinical Oncology 50, no. 11 (2020): 1325–29. http://dx.doi.org/10.1093/jjco/hyaa135.
Pełny tekst źródłaP. G., Naveen, and K. Veena L. Karanth. "Derived neutrophil by lymphocytes ratio is a misnomer, implication of derived leucocytes ratio in diagnosing gastric cancers." International Surgery Journal 6, no. 1 (2018): 82. http://dx.doi.org/10.18203/2349-2902.isj20185187.
Pełny tekst źródłaKim, Sunsuk, Moon Kyung Joo, Jong-Jae Park, et al. "Neutrophil-to-lymphocyte ratio to predict metachronous cancer after curative resection of early gastric cancer." Journal of Clinical Oncology 42, no. 3_suppl (2024): 313. http://dx.doi.org/10.1200/jco.2024.42.3_suppl.313.
Pełny tekst źródłaGawiński, Cieszymierz, Andrzej Mróz, Katarzyna Roszkowska-Purska, et al. "A Prospective Study on the Roles of the Lymphocyte-to-Monocyte Ratio (LMR), Neutrophil-to-Lymphocyte Ratio (NLR), and Platelet-to-Lymphocyte Ratio (PLR) in Patients with Locally Advanced Rectal Cancer." Biomedicines 11, no. 11 (2023): 3048. http://dx.doi.org/10.3390/biomedicines11113048.
Pełny tekst źródłaYasuda, Koji. "The correlation of neutrophil/lymphocyte ratio and tumor reduction ratio in preoperative chermoradiotherapy for advanced rectal cancer." Journal of Clinical Oncology 32, no. 3_suppl (2014): 633. http://dx.doi.org/10.1200/jco.2014.32.3_suppl.633.
Pełny tekst źródłaRozprawy doktorskie na temat "Cancer ratio"
Lee, Karin L. "High Aspect Ratio Viral Nanoparticles for Cancer Therapy." Case Western Reserve University School of Graduate Studies / OhioLINK, 2016. http://rave.ohiolink.edu/etdc/view?acc_num=case1467714833.
Pełny tekst źródłaStenning, Persivale Karoline Andrea, Franco Maria Jose Savitzky, Alejandra Cordero-Morales, et al. "The mortality-incidence ratio as an indicator of five-year cancer survival in metropolitan Lima." Cancer Intelligence, 2018. http://hdl.handle.net/10757/622636.
Pełny tekst źródłaGunnarsson, Niklas. "Chronic myeloid leukemia and cancer." Doctoral thesis, Umeå universitet, Medicin, 2017. http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-141144.
Pełny tekst źródłaCameron, David. "Alterations in the apoptotic-mitotic ratio : an early indicator of breast cancer sensitivity to tamoxifen." Thesis, University of Edinburgh, 1997. http://hdl.handle.net/1842/21677.
Pełny tekst źródłaForoughi, pour Ali. "Linear Approximations for Second Order High Dimensional Model Representation of the Log Likelihood Ratio." The Ohio State University, 2019. http://rave.ohiolink.edu/etdc/view?acc_num=osu1555419601408423.
Pełny tekst źródłaKIKOSADA, Yasutomi, Hisatoshi MAEDA, Manabu ANDOH та ін. "異数倍数体を示す上咽頭腫瘍におけるmagnetization transfer ratio". 日本磁気共鳴医学会, 1996. http://hdl.handle.net/2237/19431.
Pełny tekst źródłaBoudria, Asma. "Les variants d'épissage du VEGF-A : leur rôle dans la progression et la réponse aux thérapies anti-angiogéniques des carcinomes pulmonaires." Thesis, Grenoble, 2014. http://www.theses.fr/2014GRENV010/document.
Pełny tekst źródłaKardeby, Caroline. "The Concordance between Immunohistochemical Staining and Silver In Situ Hybridization for HER2 Status in Breast Cancer Tissue Samples." Thesis, Uppsala universitet, Institutionen för medicinsk biokemi och mikrobiologi, 2011. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-154951.
Pełny tekst źródłaSouza, Lima Nathalia Caroline de 1989. "Relation between digit ratio (2D:4D) and malignant and benign breast lesions = Relação entre proporção digital (2D:4D) e lesões malignas e benignas de mama." [s.n.], 2014. http://repositorio.unicamp.br/jspui/handle/REPOSIP/289238.
Pełny tekst źródłaGrundmark, Birgitta. "Prostate Cancer; Metabolic Risk Factors, Drug Utilisation, Adverse Drug Reactions." Doctoral thesis, Uppsala universitet, Institutionen för kirurgiska vetenskaper, 2013. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-194297.
Pełny tekst źródłaKsiążki na temat "Cancer ratio"
Anscher, Mitchell S., and Kristoffer Valerie, eds. Strategies to Enhance the Therapeutic Ratio of Radiation as a Cancer Treatment. Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-45594-5.
Pełny tekst źródłaBonavida, Benjamin, ed. Sensitization of Cancer Cells for Chemo/Immuno/Radio-therapy. Humana Press, 2008. http://dx.doi.org/10.1007/978-1-59745-474-2.
Pełny tekst źródłaBenjamin, Bonavida, ed. Sensitization of cancer cells for chemo/immuno/radio-therapy. Humana Press, 2008.
Znajdź pełny tekst źródłaInternational Meeting on Progress in Radio-Oncology (6th 1998 Salzburg, Austria). Progress in radio-oncology VI: Proceedings of the 6th International Meeting on Progress in Radio-Oncology : ICRO/ ÖGRO 6 : Salzburg, Austria, May 13-17, 1998. Edited by Kogelnik H. Dieter and Sedlmayer Felix. Monduzzi Editore, International Proceedings Division, 1998.
Znajdź pełny tekst źródłaInternational Meeting on Progress in Radio-Oncology (5th 1995 Salzburg, Austria). Progress in radio-oncology V: Proceedings of the 5th International Meeting on Progress in Radio-Oncology, ICRO/ÖGRO 5, Salzburg (Austria), May 10-14, 1995. Edited by Kogelnik H. D. Monduzzi Editore, International Proceedings Division, 1995.
Znajdź pełny tekst źródłaInternational, Meeting on Progress in Radio-Oncology (7th 2002 Salzburg Austria). Progress in radio-oncology VII: Proceedings of the 7th International Meeting on Progress in Radio-Oncology, ICRO/ÖGRO 7 : Salzburg, Austria, May 15-19, 2002. Monduzzi Editore, International Proceedings Division, 2001.
Znajdź pełny tekst źródłaCarlo, George Louis. Cell phones: Invisible hazards in the wireless age : an insider's alarming discoveries about cancer and genetic damage. Carroll & Graf Publishers, Inc., 2001.
Znajdź pełny tekst źródłaAbadie, Horacio. Charlemos de vos: Historias de vida en Abran Cancha. Planeta, 2020.
Znajdź pełny tekst źródłaC, Srivastava Suresh, and North Atlantic Treaty Organization. Scientific Affairs Division., eds. Radiolabeled monoclonal antibodies for imaging and therapy. Plenum Press, 1988.
Znajdź pełny tekst źródłaCzęści książek na temat "Cancer ratio"
Keaton, Jeffrey R. "Poisson’s Ratio." In Selective Neck Dissection for Oral Cancer. Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-12127-7_225-1.
Pełny tekst źródłaZhigalin, Aleksandr. "Velocity Ratio." In Selective Neck Dissection for Oral Cancer. Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-12127-7_289-1.
Pełny tekst źródłaKeaton, Jeffrey R. "California Bearing Ratio." In Selective Neck Dissection for Oral Cancer. Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-12127-7_39-1.
Pełny tekst źródłaCoderre, J. A., G. M. Morris, P. L. Micca, et al. "The Therapeutic Ratio in BNCT." In Cancer Neutron Capture Therapy. Springer US, 1996. http://dx.doi.org/10.1007/978-1-4757-9567-7_107.
Pełny tekst źródłaStieve, Friedrich-Ernst. "A Topical View of the Benefit-Risk Ratio in Mammography." In Early Breast Cancer. Springer Berlin Heidelberg, 1985. http://dx.doi.org/10.1007/978-3-642-70192-4_14.
Pełny tekst źródłaRajan, Jay, Keth Pride, and Peggy Y. Kim. "Benefit to Burden Ratio in Treating Cancer Pain." In Pain. Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-319-99124-5_209.
Pełny tekst źródłaMarcus, Pamela M. "Closing Thoughts." In Assessment of Cancer Screening. Springer International Publishing, 2022. http://dx.doi.org/10.1007/978-3-030-94577-0_10.
Pełny tekst źródłaChung, Su I., DeeDee K. Smart, Eun Joo Chung, and Deborah E. Citrin. "Radioprotection as a Method to Enhance the Therapeutic Ratio of Radiotherapy." In Cancer Drug Discovery and Development. Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-40854-5_4.
Pełny tekst źródłaCarruthers, Ross, and Anthony J. Chalmers. "Improving the Therapeutic Ratio of Radiotherapy by Targeting the DNA Damage Response." In Cancer Drug Discovery and Development. Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-40854-5_1.
Pełny tekst źródłaKamano, Toshiki, Kei Nakamura, Youshi Mikami, Noburu Sakakibara, Motonari Kano, and Masaru Matsumoto. "Significance of Fecal Bile Acid Ratio in Colorectal Cancer Patients." In Recent Advances in Management of Digestive Cancers. Springer Japan, 1993. http://dx.doi.org/10.1007/978-4-431-68252-3_134.
Pełny tekst źródłaStreszczenia konferencji na temat "Cancer ratio"
Khan, Aamir A., Genevieve D. Vigil, Yide Zhang, and Scott S. Howard. "Theoretical Analysis of the Signal-to-Noise Ratio of Two-Photon Oxygen Imaging Probes." In Cancer Imaging and Therapy. OSA, 2016. http://dx.doi.org/10.1364/cancer.2016.jw3a.48.
Pełny tekst źródłaSingh, Nisha, Deepshikha Rajput, and Shuchi Agrawal. "EP305/#401 Neutrophil lymphocyte ratio and platelet lymphocyte ratio as prognostic markers in ovarian cancer." In IGCS 2023 Annual Meeting Abstracts. BMJ Publishing Group Ltd, 2023. http://dx.doi.org/10.1136/ijgc-2023-igcs.368.
Pełny tekst źródłaHuszno, J., Z. Kołosza, J. Mrochem Kwarciak, T. Rutkowski, and K. Składowski. "Abstract P2-08-49: The role of neutrophil–lymphocyte ratio (NLR), platelet–lymphocyte ratio (PLR) andmonocyte – lymphocyte ratio (MLR) in prognosis of breast cancer patients." In Abstracts: 2018 San Antonio Breast Cancer Symposium; December 4-8, 2018; San Antonio, Texas. American Association for Cancer Research, 2019. http://dx.doi.org/10.1158/1538-7445.sabcs18-p2-08-49.
Pełny tekst źródłaOrlandini, Leonardo Fleury, Franklin Fernandes Pimentel, Jurandyr Moreira de Andrade, Francisco José Cândido dos Reis, Leticia De Mattos Arruda, and Daniel Guimarães Tiezzi. "HIGH NEUTROPHIL-TO-LYMPHOCYTE RATIO IS PROGNOSTIC FACTOR IN EARLY-STAGE BREAST CANCER PATIENTS." In Abstracts from the Brazilian Breast Cancer Symposium - BBCS 2021. Mastology, 2021. http://dx.doi.org/10.29289/259453942021v31s2038.
Pełny tekst źródłaZribi, Aref, Amnah Faisal Ahmed, Hasan Khalid Alsayegh, and Ikram A. Burney. "EV174/#209 Prognostic value of neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in high-grade endometrial cancer." In IGCS 2024 Annual Meeting Abstracts. BMJ Publishing Group Ltd, 2024. http://dx.doi.org/10.1136/ijgc-2024-igcs.293.
Pełny tekst źródłaDas, B. B., R. R. Alfano, J. Cleary, R. Prudente, and E. Celmer. "UV-fluorescence spectroscopy distinguishes breast cancer from benign tumors." In OSA Annual Meeting. Optica Publishing Group, 1990. http://dx.doi.org/10.1364/oam.1990.tuoo7.
Pełny tekst źródłaButtros, Daniel, Caroline Nakano Vitorino, Heloisa Maria de Luca Vespoli, Rafaela Caroline de Souza, and Eliana Aguiar Petri Nahás. "Negative impact of adjuvant endocrine therapy on sexual function in breast cancer survivors." In Brazilian Breast Cancer Symposium 2023. Mastology, 2023. http://dx.doi.org/10.29289/259453942023v33s1037.
Pełny tekst źródłaScelo, Ghislaine, Estelle Chanudet-van den Brink, Peng Li, Chanida Vinayanuwattikun, and David C. Muller. "Abstract 5213: Remarkably stable sex-ratio in sporadic kidney cancer incidence." In Proceedings: AACR 107th Annual Meeting 2016; April 16-20, 2016; New Orleans, LA. American Association for Cancer Research, 2016. http://dx.doi.org/10.1158/1538-7445.am2016-5213.
Pełny tekst źródłaMansouri, Houyem, Ines Zemni, Sabrine Boukhris, Houda Henchiri, Racha Ben Romdhan, and Leila Achouri. "399 Prognostic significance of lymph node ratio in early breast cancer." In ESGO 2024 Congress Abstracts. BMJ Publishing Group Ltd, 2024. http://dx.doi.org/10.1136/ijgc-2024-esgo.844.
Pełny tekst źródłaHayashi, Tomomi, Junichiro Watanabe, and Shyogo Nakamoto. "Abstract P1-10-25: The prognostic and predictive roles of the neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and lymphocyte-to-monocyte ratio in HER2-negative metastatic breast cancer patients treated with paclitaxel-bevacizumab." In Abstracts: 2019 San Antonio Breast Cancer Symposium; December 10-14, 2019; San Antonio, Texas. American Association for Cancer Research, 2020. http://dx.doi.org/10.1158/1538-7445.sabcs19-p1-10-25.
Pełny tekst źródłaRaporty organizacyjne na temat "Cancer ratio"
Zhang, Dan, Jingting Liu, Mengxia zheng, Chunyan Meng, and Jianhua Liao. Prognostic and Clinicopathological significance of CD155 Expression in Cancer Patients: A Meta-Analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2022. http://dx.doi.org/10.37766/inplasy2022.9.0087.
Pełny tekst źródłaKahwati, Leila, Matthew Avenarius, Leslie Brouwer, et al. Blood-Based Tests for Multiple Cancer Screening: A Systematic Review. AHRQ, 2025. https://doi.org/10.23970/ahrqepcsrmultiple.
Pełny tekst źródłaGupta, Arti, and Pankaj Kumar Gupta. HISTOPATHOLOGICAL DISTRIBUTION OF MALIGNANT CASES IN A TERTIARY CARE CENTRE. World Wide Journals, 2023. http://dx.doi.org/10.36106/ijar/1007787.
Pełny tekst źródłaHudson, Alana. The Impact of the 6:3 Polyunsaturated Fatty Acid Ratio on Intermediate Markers of Breast Cancer. Defense Technical Information Center, 2008. http://dx.doi.org/10.21236/ada485713.
Pełny tekst źródłaHudson, Alana. The Impact of the 6:3 Polyunsaturated Fatty Acid Ratio on Intermediate Markers of Breast Cancer. Defense Technical Information Center, 2007. http://dx.doi.org/10.21236/ada471158.
Pełny tekst źródłaLi, Binfeng, Fei Xiong, Shengzhong Yi, and Sheng Wang. Prognostic and Clinicopathologic Significance of Neutrophil-to-lymphocyte Ratio in Esophageal Cancer: An Update Meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2021. http://dx.doi.org/10.37766/inplasy2021.10.0111.
Pełny tekst źródłaSu, Yanguang, Juanli Chen, Lingjun Du, and Xudong Liu. Prognostic and clinicopathological value of fibrinogen-to-albumin ratio (FAR) in colorectal cancer: a meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2024. https://doi.org/10.37766/inplasy2025.3.0034.
Pełny tekst źródłaZhang, Dongyuan, Zhengze Wang, Jingwen Li, Chengliang Ren, and Shen Tian. Neutrophil-to-lymphocyte ratio in head and neck cancer prognosis: An updated systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2020. http://dx.doi.org/10.37766/inplasy2020.9.0074.
Pełny tekst źródłaLiu, Ye, Xiaodi Li, Xiaoli Gao, and Xiaoling Jin. Prognostic and clinicopathological value of fibrinogen-to-albumin ratio in patients with esophageal cancer: A meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2025. https://doi.org/10.37766/inplasy2025.6.0005.
Pełny tekst źródłaYang, Fan, Zhaofeng Wang, and Minming Wang. Prognostic value of lymphocyte-to-monocyte ratio in patients with small cell lung cancer: a meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2025. https://doi.org/10.37766/inplasy2025.7.0051.
Pełny tekst źródła